Topic

Lamzede (velmanase alfa-tycv)

A collection of 24 issues

Renewing Lamzede (Velmanase Alfa-tycv) Approval with Aetna in Texas: Complete 2024 Guide to Reauthorization, Documentation, and Appeals

Answer Box: Renewing Lamzede with Aetna in Texas Lamzede (velmanase alfa-tycv) requires annual reauthorization with Aetna. Start the renewal process 60 days before your current authorization expires. You'll need updated clinical documentation showing continued benefit: improved or stable 6-minute walk test, pulmonary function (FVC), or reduced serum oligosaccharides.
6 min read

How to Get Lamzede (velmanase alfa-tycv) Covered by Aetna in North Carolina: PA Requirements, Appeals, and Smart NC External Review

Quick Answer: Getting Lamzede Covered by Aetna in North Carolina Aetna requires prior authorization for Lamzede (velmanase alfa-tycv) in 2024. To get coverage, you need: confirmed alpha-mannosidosis diagnosis (enzyme deficiency or MAN2B1 genetic testing), specialist prescriber, and clinical documentation. If denied, North Carolina's Smart NC program offers external
5 min read